Mark Becker

937 total citations
10 papers, 731 citations indexed

About

Mark Becker is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Management of Technology and Innovation. According to data from OpenAlex, Mark Becker has authored 10 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Management of Technology and Innovation. Recurrent topics in Mark Becker's work include Radiopharmaceutical Chemistry and Applications (3 papers), Organ Donation and Transplantation (3 papers) and Blood transfusion and management (3 papers). Mark Becker is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Organ Donation and Transplantation (3 papers) and Blood transfusion and management (3 papers). Mark Becker collaborates with scholars based in United States, Japan and Switzerland. Mark Becker's co-authors include Kirk Trisler, David J. Adelstein, Michael L. Goris, Susan J. Knox, Paul Chinn, Carol Marquez, Nimisha Deb, Antonio J Grillo-López, Ronald Levy and C. Varns and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Mark Becker

10 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Becker United States	7	334	330	207	199	172	10	731
Feng-yi Feng China	8	345 1.0×	109 0.3×	129 0.6×	81 0.4×	450 2.6×	35	673
Vivian Ng United States	7	404 1.2×	376 1.1×	99 0.5×	60 0.3×	709 4.1×	10	955
Naoki Takegawa Japan	13	308 0.9×	256 0.8×	156 0.8×	48 0.2×	533 3.1×	28	732
Alice E. Guardino United States	9	114 0.3×	226 0.7×	69 0.3×	128 0.6×	477 2.8×	13	745
Shu-Fang Hsu Schmitz Switzerland	6	345 1.0×	89 0.3×	47 0.2×	167 0.8×	287 1.7×	9	577
Jobst C. von Einem Germany	15	178 0.5×	65 0.2×	140 0.7×	157 0.8×	456 2.7×	33	659
Eric Cheung United States	11	112 0.3×	79 0.2×	39 0.2×	228 1.1×	244 1.4×	21	498
Kerry Horgan United States	9	246 0.7×	136 0.4×	250 1.2×	276 1.4×	353 2.1×	13	962
Bernhard Heinrich Germany	14	187 0.6×	129 0.4×	52 0.3×	37 0.2×	439 2.6×	36	630
Hong Xie United States	13	91 0.3×	101 0.3×	135 0.7×	59 0.3×	406 2.4×	29	739

Countries citing papers authored by Mark Becker

Since Specialization

Citations

This map shows the geographic impact of Mark Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Becker more than expected).

Fields of papers citing papers by Mark Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Becker. The network helps show where Mark Becker may publish in the future.

Co-authorship network of co-authors of Mark Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Becker. A scholar is included among the top collaborators of Mark Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Becker. Mark Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Becker, Mark, et al.. (2023). Why do US source plasma donors stop donating?. Transfusion. 63(10). 1904–1915. 4 indexed citations

Becker, Mark, et al.. (2023). Effects of donation frequency on U.S. source plasma donor health. Transfusion. 63(10). 1885–1903. 3 indexed citations

Schreiber, George B., et al.. (2021). Plasmavigilance—Adverse events among US Source plasma donors. Transfusion. 61(10). 2941–2957. 12 indexed citations

Mahadevan, Daruka, E. Gabriela Chiorean, Daniel D. Von Hoff, et al.. (2012). Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies. European Journal of Cancer. 48(18). 3319–3327. 107 indexed citations

Mahadevan, Daruka, E. Gabriela Chiorean, Daniel D. Von Hoff, et al.. (2011). Phase I study of the multikinase prodrug SF1126 in solid tumors and B-cell malignancies.. Journal of Clinical Oncology. 29(15_suppl). 3015–3015. 10 indexed citations

Zuccaro, Gregory, Thomas W. Rice, John R. Goldblum, et al.. (1999). Endoscopic Ultrasound Cannot Determine Suitability for Esophagectomy After Aggressive Chemoradiotherapy for Esophageal Cancer. The American Journal of Gastroenterology. 94(4). 906–912. 116 indexed citations

Adelstein, David J., Thomas W. Rice, Mark Becker, et al.. (1997). Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer. 80(6). 1011–1020. 90 indexed citations

Trisler, Kirk, et al.. (1996). Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody.. PubMed. 2(8). 1289–97. 110 indexed citations

Knox, Susan J., Michael L. Goris, Kirk Trisler, et al.. (1996). Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.. PubMed. 2(3). 457–70. 273 indexed citations

10.

Knox, Susan J., Michael L. Goris, Kirk Trisler, et al.. (1995). 148 90Y-anti-CD20 monoclonal antibody therapy for recurrent B cell lymphoma. International Journal of Radiation Oncology*Biology*Physics. 32. 215–215. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact